.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

New injection relieves symptoms of Crohn's disease

April 24, 2008

UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.

Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this